Press Foreign

India Founded: 2021 • Age: 5 yrs
Indian firm specializing in medical devices and leadership announcements in healthcare.

About Press Foreign

Press Foreign is a Healthcare company based in India founded in 2021. Indian firm specializing in medical devices and leadership announcements in healthcare. It operates on a B2B model. The company has 578 employees. Its Indian entity Bpl Medical Technologies Private Limited reported revenue of β‚Ή516 Cr. Press Foreign offers products and services including Medical Devices. Its focus areas include Health, Medical Devices, Devices Manufacturing and Healthcare Equipment.

Company details

BPL Medical Technologies Pvt. Ltd. is a prominent medical devices company based in Bengaluru, India. It focuses on manufacturing and innovating medical devices for the healthcare sector, serving domestic markets with key products. The company recently announced leadership changes to enhance operations and drive growth. Its activities include device development and market distribution, aiming to improve healthcare outcomes through reliable technology.

Key Metrics
  • Annual Revenue
    ₹516 Cr

    FY 2025 · +1% YoY

  • Net Profit
    ₹17 Lakh

    FY 2025 · 0% margin

  • EBITDA
    ₹19.49 Cr

    FY 2025 · 4% margin

  • Employee Count
    578

Products & Services of Press Foreign

Press Foreign offers a comprehensive portfolio of products and services, including Medical Devices.

Medical Devices
Healthcare Products

Products for medical applications and diagnostics in healthcare

Board of directors of Bpl Medical Technologies Private Limited (Press Foreign)

Bpl Medical Technologies Private Limited is the primary company behind Press Foreign. The board of Bpl Medical Technologies Private Limited currently have 8 directors; the longest-serving is Anju Chandrasekhar, appointed in 2013. 18 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Anju Chandrasekhar
DIN 00228746
Director10 Aug 201313 yrs 3 moBpl Medical Technologies Private Limited
Ajit Gopal Nambiar
DIN 00228857
Director10 Aug 201313 yrs 3 moBpl Medical Technologies Private Limited
Sunil Kumar Khurana
DIN 06642212
Whole-time director12 Aug 201313 yrs 2 moBpl Medical Technologies Private Limited
Shravan Subramanyam
DIN 00695586
Managing Director02 Apr 20251 yr 7 moBpl Medical Technologies Private Limited
Guruswamy Krishnamoorthy
DIN 00611506
CEO02 Apr 20251 yr 7 moBpl Medical Technologies Private Limited
Chandra Sekhar Reddy Garisa
DIN 03057784
Nominee Director12 May 20251 yr 5 moBpl Medical Technologies Private Limited
Dilip Jose Puthiyidathu
DIN 03591692
Nominee Director28 May 20251 yr 5 moBpl Medical Technologies Private Limited
Abhay Maheshwari
DIN 08004819
Nominee Director08 Dec 202511 moBpl Medical Technologies Private Limited

Financials of Press Foreign

Figures of Bpl Medical Technologies Private Limited, the primary company behind Press Foreign, for FY 2025. Revenue was ₹516 Cr (+1% year on year). Net profit was ₹17 Lakh (0% margin). EBITDA was ₹19.49 Cr (4% margin). Revenue has grown at a compounded annual rate of -9% over three years and +8% over five years.

  • ₹516 CrRevenue · FY 2025 · +1% YoY
  • ₹17 LakhNet profit · 0% margin
  • ₹19.49 CrEBITDA · 4% margin
  • ₹143 CrPaid-up capital
  • 578Employees (provident fund records)
  • -9%Revenue CAGR, 3 years
  • +8%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bpl Medical Technologies Private Limited are on its company page.

Premium access

Detailed financial statements for Press Foreign

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Press Foreign

Premium access

Complete news archive for Press Foreign

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Press Foreign

Press Foreign was founded in 2021.

Press Foreign is headquartered in India.

Press Foreign has 578 employees.

The primary company behind Press Foreign, Bpl Medical Technologies Private Limited, reported revenue of β‚Ή516 Cr for FY 2025, up 1% year on year.

BPL Medical Technologies Pvt. Ltd. is a prominent medical devices company based in Bengaluru, India. It focuses on manufacturing and innovating medical devices for the healthcare sector, serving domestic markets with key products. The company recently announced leadership changes to enhance operations and drive growth. Its activities include device development and market distribution, aiming to improve healthcare outcomes through reliable technology.

Press Foreign offers Medical Devices.

Press Foreign operates through Bpl Medical Technologies Private Limited.

The legal entities of Press Foreign currently have 10 directors, including Anju Chandrasekhar, Ajit Gopal Nambiar, Chandra Sekhar Reddy Garisa and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available